Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

NCT03475186 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Radiotherapy; Complications
Cognitive Decline
Chemoradiation

Interventions

DRUG: Ramipril

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]